ouabain has been researched along with 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hata, F; Ishii, T; Nishio, H; Saitoh, N; Sunami, O; Takeuchi, T | 1 |
1 other study(ies) available for ouabain and 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate
Article | Year |
---|---|
Inhibition of skeletal muscle sarcoplasmic reticulum Ca2+-ATPase by nitric oxide.
Topics: Aminoquinolines; Animals; Caffeine; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium-Transporting ATPases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dithiothreitol; Guanylate Cyclase; Heparin; Inositol 1,4,5-Trisphosphate; Nitric Oxide; Ouabain; Rabbits; Ryanodine; Sarcoplasmic Reticulum; Sodium-Potassium-Exchanging ATPase; Thapsigargin; Thionucleotides | 1998 |